QR код

Treatment of atopic dermatitis with upadacitinib: adcare single center experience

IntroductionThe role of upadacitinib in the management of moderate to severe atopic dermatitis seems promising, but more data on its efficacy and safety are needed. This study endeavors to assess the practical impact and safety of upadacitinib in patients with moderate to severe atopic dermatitis. T...

Повний опис

Збережено в:
Автори: Daria S. Fomina, Olga A. Mukhina, Valeria I. Mikhailova, Marina S. Lebedkina, Elizaveta L. Sedova, Elena N. Bobrikova, Olga G. Elisyutina, Elena S. Fedenko, Tair T. Nurpeisov, Alexander V. Karaulov, Mar’yana A. Lysenko, Luis Felipe C. Ensina
Формат: Artigo
Мова:Inglês
Опубліковано: Frontiers Media S.A. 2024-04-01
Серія:Frontiers in Medicine
Предмети:
upadacitinib
atopic dermatitis
drug efficacy and safety
Eczema Area and Severity Index
Janus kinase inhibitors molecules
Онлайн доступ:https://www.frontiersin.org/articles/10.3389/fmed.2024.1385720/full
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси